Snizavich v. Dow Chemical Co.

27 Pa. D. & C.5th 185
CourtPennsylvania Court of Common Pleas, Philadelphia County
DecidedNovember 19, 2012
DocketNo. 2832
StatusPublished

This text of 27 Pa. D. & C.5th 185 (Snizavich v. Dow Chemical Co.) is published on Counsel Stack Legal Research, covering Pennsylvania Court of Common Pleas, Philadelphia County primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Snizavich v. Dow Chemical Co., 27 Pa. D. & C.5th 185 (Pa. Super. Ct. 2012).

Opinion

DIVITO, J.,

This is based upon an appeal by Anne Snizavich (“plaintiff’), individually and as the administrator of the estate of Joseph Snizavich (“decedent”) from the court’s order entered on April 17, [187]*1872012 granting Dow Chemical Company and Rohm and Haas Company’s (“defendants”) motion to preclude the testimony of Thomas H. Milby. For the reasons that follow, the order by the court granting the motion should be affirmed as well as the subsequent order granting the defendants’ motion for summary judgment.

I. Background

Plaintiff in her complaint alleged that her husband Joseph Snizavich, who died on September 19, 2008 as a result of Glioblastoma Multiforme brain cancer, developed cancer as a result of chemicals that the decedent was exposed to during the time that he worked at defendants’ facilities in Spring House, Pennsylvania. The decedent was not an employee of the defendants, but rather was employed by an outside contractor, the Welsch Company, to perform HVAC work at the Spring House location. Plaintiff alleges that the decedent worked at the Spring House location for approximately 13 years between 1980 to 1993.

In support of the plaintiff’s allegations that the decedent’s cancer was a result of exposure to chemicals at the Spring House facility, she submitted a report (“Milby Report”) written by Thomas Milby, M.D. (“Milby”) stating that it was his opinion that chemicals produced by Rohm and Haas at the Spring House location were the cause of the Glioblastoma Multiforme cancer. Milby identified three events which he considered “crucial” in coming to his opinion, 1) the decedent worked at the Spring House facility for 13 years during which time he [188]*188was exposed to various chemicals, none of which were named or discussed in the report; 2) the decedent died of a brain cancer that accounts for approximately 2.4% of cancer deaths in the United States; 3) a University of Minnesota School of Public Health report (“University of Minnesota Report”) showed that there was a higher than average incidence of brain cancer deaths among Spring House facility employees but that no clear link existed between the chemicals used at Spring House and the higher incidence of brain cancer.1

In response to the Milby Report, defendants filed a motion to preclude the testimony of Thomas H. Milby. The motion was granted by the court on the grounds that the report was wholly inadequate under Pennsylvania law as failing to provide a “reasonable degree of medical certainty” and that any sort of Frye analysis of its methodology would be futile as none apparently existed within the report. Further, as the plaintiff had shown no evidence or expert testimony causally linking the defendants to the decedent’s illness and death, the motion of the defendants for summary judgment was granted. The plaintiff now appeals those rulings.

II. Plaintiff’s Matters Complained of on Appeal

The plaintiff in her statement of errors complained of on appeal lists several points of contention, however, they can be summed up as stating that the court erroneously [189]*189precluded the Milby Report and testimony, did not conduct a full Frye analysis, and, subsequently, granted the defendants’ motion for summary judgment.

Whether expert testimony regarding scientific knowledge should be admissible is controlled by Pennsylvania Rule of Evidence 702, which states:

If scientific, technical or other specialized knowledge beyond that possessed by a layperson will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training or education may testify thereto in the form of an opinion or otherwise. Pa.R.E. 702

The Frye analysis, first formulated in Frye v. United States, 293 F. 1013 (D.C. Cir. 1923), and adopted by Pennsylvania in Commonwealth v. Topa, 471 Pa. 223, 369 A.2d 1277 (1977), is considered to be a part of Rule 702. The Pennsylvania Supreme court has stated that, “Under Frye, novel scientific evidence is admissible if the methodology that underlies evidence has general acceptance in the relevant scientific community.” Grady v. Frito-Lay, Inc., 576 Pa. 546, 555, 839 A.2d 1038, 1044 (2003). Hence, for a Frye analysis to be performed there must be some type of underlying methodology for a court to be able to analyze.

In applying a Frye analysis the Pennsylvania Supreme court stated four points that a court should consider. First, “the proponent of a proposition bears the burden of [190]*190proving it [and] we emphasize that the proponent of expert scientific evidence bears the burden of establishing all of the elements for its admission under Pa.R.E. 702.” Grady, 576 Pa. at 558, 839 A.2d at 1045. Secondly, the proponent is required to “prove that the methodology an expert used is generally accepted by scientists in the relevant field as a method for arriving at the conclusion the expert will testify to at trial.” Id. Third, under Pa.R.E. The Frye requirement is only one of several criteria, including the expertise of the witness presenting the scientific evidence. Id. at 1045-46. Finally, the court reiterated:

[T]he admission of expert scientific testimony is an evidentiary matter for the trial court’s discretion and should not be disturbed on appeal unless the trial court abuses its discretion. An abuse of discretion may not be found merely because an appellate court might have reached a different conclusion, but requires a result of manifest unreasonableness, or partiality, prejudice, bias, or ill-will, or such lack of support so as to be clearly erroneous. Id. at 1046 (Internal Citations Omitted).

The rules in granting summary judgment are well known and based uponPa.R.C.P. 1035.2. Itfindsthat, “where there is no genuine issue of material fact and the moving party is entitled to relief as a matter of law, summary judgment may be entered. Where the non-moving party bears the burden of proof on an issue, he may not merely rely on his pleadings or answers in order to survive summary judgment.” ADP, Inc. v. Morrow Motors Inc., 969 A.2d 1244, 1246 (Pa. Super. 2009). Furthermore, “failure of [191]*191a non-moving party to adduce sufficient evidence on an issue essential to his case and on which he bears the burden of proof establishes the entitlement of the moving party to judgment as a matter of law.” Id.

Based on the foregoing, it was not necessary to conduct a full Frye analysis on the report issued by Milby, as it failed both of the basic requirements of showing a coherent scientific or technical methodology to which any type of analysis could be applied as to its acceptance in the scientific community or showing that its conclusions would in any way assist the trier of fact to understand the evidence or a fact in issue. The report is nothing more than conclusions, without any apparent basis in scientific studies or research, being supported by large leaps in logic and anecdotal evidence of other individuals who worked at the Spring House facility having died of brain cancer.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Grady v. Frito-Lay, Inc.
839 A.2d 1038 (Supreme Court of Pennsylvania, 2003)
Commonwealth v. Topa
369 A.2d 1277 (Supreme Court of Pennsylvania, 1977)
ADP, INC. v. Morrow Motors Inc.
969 A.2d 1244 (Superior Court of Pennsylvania, 2009)
Frye v. United States
293 F. 1013 (D.C. Circuit, 1923)

Cite This Page — Counsel Stack

Bluebook (online)
27 Pa. D. & C.5th 185, Counsel Stack Legal Research, https://law.counselstack.com/opinion/snizavich-v-dow-chemical-co-pactcomplphilad-2012.